corporary

INTERLEUKINE

Active
SIREN 904129111 VAT number FR13904129111

Business purpose.

Detention de titres de sociétés d'exercice libéral ayant pour objet l'exercice de la profession de médecin ou de tout groupement de droit étranger ayant le même objet

Identity

Legal form
SPFPL holding company for regulated professions, as an SAS (SPFPL SAS)
Activity
Trusts, funds and similar financial entities (64.30Z)
Sector
Financial service activities, except insurance and pension funding
Headcount
Headcount unknown
Created
6 Oct 2021
Share capital
1,200.00 EUR
Registered with the trade register
12 Oct 2021
Financial year end
31/12
Establishments
1

Directors

Related companies

Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.

Other companies at the same address

204 other company head offices are registered at this address.

Establishments

Financial strength

Financial score

62 / 100 C

Confidence: low · computed on the financial year ended 31 Dec 2024

Equity to assets (56.9 %)
20.5 out of 30
EBITDA margin
data missing, component not taken into account
Liquidity (294.4 %)
11.7 out of 20
Debt (75.0 %)
8.2 out of 15
Revenue trend
data missing, component not taken into account

formula fin-1.0

Legal score

90 / 100 A

Confidence: high

No insolvency proceedings
40.0 out of 40
Currently trading
20.0 out of 20
Age (5.1 years)
10.3 out of 20
Accounts filed recently
20.0 out of 20

formula leg-1.0

These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated

Revenue and earnings

Detailed accounts for this company are not reproduced here, but its main aggregates are public.

Revenue and net income by financial year
2023 2024

Revenue Net income

Financial year Revenue Change EBITDA Net income
31 Dec 2024 0 € — -1,202 € 40,409 €
31 Dec 2023 0 € first year on record -1,131 € 35,926 €

Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.

Explore similar companies

Legal notices

  • Filing of accounts 13 Sep 2026
    Court :
    Greffe du Tribunal des Activités Economiques de limoges
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2025

    BODACC C n 20260175, annonce n 5772 · Proof of publication (PDF)

  • Filing of accounts 30 Jul 2025
    Court :
    Greffe du Tribunal des Activités Economiques de limoges
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2024

    BODACC C n 20250144, annonce n 8154 · Proof of publication (PDF)

  • Filing of accounts 16 Jul 2024
    Court :
    Greffe du Tribunal de Commerce de limoges
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2023

    BODACC C n 20240136, annonce n 8611 · Proof of publication (PDF)

  • Filing of accounts 3 Aug 2023
    Court :
    Greffe du Tribunal de Commerce de limoges
    Type of filing :
    Comptes annuels et rapports
    Closing date :
    31/12/2022

    BODACC C n 20230148, annonce n 15743 · Proof of publication (PDF)

  • Incorporation 22 Oct 2021
    Court :
    GREFFE DU TRIBUNAL DE COMMERCE DE LIMOGES

    BODACC A n 20210207, annonce n 1502 · Proof of publication (PDF)

Filings and annual accounts as PDF →

Change history

  • Appointed: President de SAS 9 Oct 2026
  • Share capital: 1,200 € 1 Oct 2026

Frequently asked questions about INTERLEUKINE

What is the SIREN number of INTERLEUKINE?
The SIREN number of INTERLEUKINE is 904129111. Its intra-community VAT number is FR13904129111.
Where is the head office of INTERLEUKINE?
Head office address: 18 RUE GENERAL CATROUX, 87000 LIMOGES.
When was INTERLEUKINE founded?
INTERLEUKINE was founded on 6 Oct 2021.
What does INTERLEUKINE do?
Its declared main activity is: Trusts, funds and similar financial entities (NAF code 64.30Z).
Who runs INTERLEUKINE?
The officer listed in the register is AURELIE AUDREY MARSAC (President de SAS).
What is the revenue of INTERLEUKINE?
The latest published revenue is 0 €, for the 2024 financial year.
Is INTERLEUKINE subject to insolvency proceedings?
No ongoing insolvency proceedings are published in the BODACC for this company.

In the official registers

Further reading

Show this profile on your website →

Report an error or request removal of this data